|
Web Pages |
Gleevec |
Imatinib mesylate. Features prescribing and reimbursement information for US residents. |
Unofficial Gleevec Site |
Features a history of the drug, interviews with medical professionals, message boards, FAQs, news, and an album of thank yous to Dr. Druker, Gleevec's primary researcher. |
Gleevec Information |
Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert. |
STI-571 (Gleevec): On the Path to Beating Cancer |
Interview with Dr. Brian Druker in text and audio. |
Gleevec's Glory Days |
Howard Hughes Medical Institute article, available in HTML and PDF format. |
Yahoo! Groups: Gleevec |
Discussion forum for anyone interested in Gleevec treatments. |
Gleevec Resource Center |
Features articles, news releases, FAQs, and drug information. |
Imatinib Mesylate |
Information from the RxList. |
Life Raft Group |
Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer. |
Novartis Pharmaceuticals Canada: Gleevec |
Prescribing and patient information, from the manufacturer. |
STI571 Digest |
Reports, news releases, list of current drug trials, and articles from the NIH's National Cancer Institute. |
Newcastle CML |
Press release about the STI571 trials in the UK. |
Imatinib ( Glivec ) – International Site |
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). |
DrugDigest: Imatinib ( Gleevec ) |
Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available. |
Gleevec Consumer Information - FDA |
Patient FAQ in html format with a link to approved labeling in pdf format. |